Progression-Free and Overall Survival for Concurrent Nivolumab With Standard Concurrent Chemoradiotherapy in Locally Advanced Stage IIIA-B NSCLC: Results From the European Thoracic Oncology Platform NICOLAS Phase II Trial (European Thoracic Oncology Platform 6-14)

Publication | Open Access

DOI Full Paper Access

130

Citations

References

2020

Year

Solange Peters, Enriqueta Felip, Urania Dafni, Amanda Tufman, Matthias Gückenberger, Ruth Álvarez, Ernest Nadal, Annemarie Becker‐Commissaris, Hansjörg Vees, Miklos Pless,

Journal of Thoracic Oncology

Health SciencesRadiation TherapyOverall SurvivalMedicineConcurrent NivolumabCancer TreatmentOncologyRadiation OncologyLung CancerRadiologyStandard Concurrent Chemoradiotherapy